"Central Co-op is a community-owned natural foods cooperative open to everyone! Owned by our shoppers and workers, we’re a complete grocery store dedicated to high-quality products, sustainable practices and strong relationships with Washington farmers and artisans."

During the past decade, CCOP - Northwest conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 41 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - Northwest" #1 sponsor was "SWOG Cancer Research Network" with 99 trials, followed by "NSABP Foundation Inc" with 15 trials sponsored, "Alliance for Clinical Trials in Oncology" with 14 trials sponsored, "Gary Morrow" with 10 trials sponsored and "Eastern Cooperative Oncology Group" with 10 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - Northwest" #1 collaborator was "National Cancer Institute (NCI)" with 165 trials as a collaborator, "Cancer and Leukemia Group B" with 18 trials as a collaborator, "SWOG Cancer Research Network" with 17 trials as a collaborator, "Eastern Cooperative Oncology Group" with 14 trials as a collaborator and "NCIC Clinical Trials Group" with 10 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - Northwest" are "Breast Cancer" (39 trials), "Lung Cancer" (24 trials), "Lymphoma" (15 trials), "Leukemia" (13 trials) and "Prostate Cancer" (13 trials). Many other conditions were trialed in "CCOP - Northwest" in a lesser frequency.

Most popular intervention types in "CCOP - Northwest" are "Drug" (138 trials), "Biological" (34 trials), "Procedure" (32 trials), "Radiation" (29 trials) and "Other" (23 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (29 trials), "radiation therapy" (20 trials), "cisplatin" (19 trials), "paclitaxel" (17 trials) and "docetaxel" (15 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - Northwest" are 112 trials for "All" genders, 43 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - Northwest". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 135 completed trials in CCOP - Northwest, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - Northwest, 1 "Phase 1" clinical trials were conducted, 71 "Phase 2" clinical trials and 79 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".